Suchergebnisse - "Marzinke, Mark A"

PubPharm (261)

1

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA) : a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

enthalten in: The lancet. HIV | 2024

von Gaur, A. | Capparelli, E. | Calabrese, K. | +40

2

Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry

enthalten in: Journal of pharmaceutical and biomedical analysis | 2024

von Pandey, A. | Price, A. | Ayala-Lopez, N. | +3

3

Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse : Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

enthalten in: The Journal of infectious diseases | 2024

von Weld, E. | McGowan, I. | Anton, P. | +22

4

Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring

enthalten in: The Journal of infectious diseases | 2024

von Stalter, R. | Dong, T. | Hendrix, C. | +30

5

Reply to Niu and Drain

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Anderson, P. | Marzinke, M. | Glidden, D.

CommentOn: Clin Infect Dis. 2024 Mar 20;78(3):801-802. - PMID 37586099

6

Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States

enthalten in: Journal of the International AIDS Society | 2024

von Liu, A. | Gundacker, H. | Richardson, B. | +14

7

Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021

enthalten in: Emerging infectious diseases | 2024

von Justman, J. | Skalland, T. | Moore, A. | +30

8

Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States

enthalten in: Journal of the International AIDS Society | 2024

von Liu, A. | Gundacker, H. | Richardson, B. | +13

9

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding : a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Landovitz, R. | Hanscom, B. | Clement, M. | +28

CommentIn: Lancet HIV. 2023 Dec;10(12):e756-e757. - PMID 37952552

10

High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda

enthalten in: bioRxiv.org | 2023

von Matthews, L. | Atukunda, E. | Owembabazi, M. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]